This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US, EU cartel enforcers seeing uptick in immunity applications as companies find themselves in 'leniency race'

By Khushita Vasant and Nicholas Hirst ( October 12, 2024, 02:03 GMT | Insight) -- The leniency program of the US Department of Justice’s antitrust division is thriving, and investigators have noticed that leniency applicants in cartel cases tend to “lose the race” as fellow cartelists beat them in reporting on the anticompetitive conduct, said Manish Kumar, the DOJ's top cartel enforcer. Maria Jaspers, a senior EU cartel enforcer, also said the competition agency is seeing an increase in the number of leniency applications for the fourth year in a row.The leniency program of the US Department of Justice’s antitrust division is thriving, and investigators have noticed that leniency applicants in cartel cases tend to “lose the race” as fellow cartelists beat them in reporting on the anticompetitive conduct, a senior DOJ official said....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections